Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

Unusual Machines Makes $30 Million Strategic Equity Investment in Powerus to Scale U.S. Autonomous Drone Manufacturing Infrastructure

Unusual Machines Makes $30 Million Strategic Equity Investment in Powerus to Scale U.S. Autonomous Drone Manufacturing Infrastructure

Unusual Machines has made a $30 million strategic equity investment in Powerus to expand the manufacturing infrastructure for autonomous drones in the U.S. This investment enhances the existing supply partnership between the two companies and aligns with their shared goal of building a robust American defense-autonomy supply chain. Powerus is also …

Kandal M Venture Secures Structured Growth Capital Facility to Fuel Philippines Manufacturing Operations

Kandal M Venture Secures Structured Growth Capital Facility to Fuel Philippines Manufacturing Operations

Kandal M Venture Limited, a Nasdaq-listed contract manufacturer of affordable luxury leather goods, has closed a $25 million structured growth capital facility through senior unsecured convertible promissory notes. The initial closing provides $1 million to fund equipment and technology upgrades for its Philippine manufacturing plant to scale capac…

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

FibroBiologics, a clinical-stage biotech company, has commenced dosing patients in its Phase 1/2 clinical trial of CYWC628, an investigational cell-based therapy for diabetic foot ulcers. Parallel advancement in manufacturing supports ongoing clinical activities, demonstrating scalability and consistency in producing CYWC628. The trial will evaluat…

AVAX One Launches AI Inference Pilot, Testing Conversion of Excess Power Capacity to Higher-Value AI Workloads

AVAX One Launches AI Inference Pilot, Testing Conversion of Excess Power Capacity to Higher-Value AI Workloads

AVAX One Technology Ltd. announced the launch of an AI inference pilot at its Redwater facility to convert approximately 100 kilowatts of excess Bitcoin mining capacity into AI workloads. The pilot aims to validate economic assumptions that AI inference can generate significantly higher revenue per kilowatt-hour than Bitcoin mining. The pilot will …

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Quoin Pharmaceuticals Announces Positive Clinical Update from Ongoing Pediatric Netherton Syndrome Compassionate Use Program

Quoin Pharmaceuticals announced positive clinical outcomes from its ongoing pediatric compassionate use program of QRX003 for Netherton Syndrome, with four of six children under 10 years old showing significant improvement and no treatment-related adverse events reported. The company plans comprehensive data releases from this program and ongoing P…

XTEND Secures Patent for Operating UAVs Under Degraded Communications and High-Latency Conditions

XTEND Secures Patent for Operating UAVs Under Degraded Communications and High-Latency Conditions

XTEND has been granted a U.S. patent covering technology that allows unmanned aerial vehicles (UAVs) to maintain precise control despite degraded communications and high latency, addressing a critical challenge in autonomous systems. This patent strengthens XTEND’s competitive position in defense and security sectors as it prepares for a business c…

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

Microbot Medical Inc. has entered an agreement with Lovell Government Services, a Service-Disabled Veteran-Owned Small Business, to facilitate access to Microbot's LIBERTY® Endovascular Robotic System for veterans, active military personnel, and Native American communities via federal healthcare systems such as the Veterans Health Administration, M…

California Resources Corporation Announces Private Offering of $550 Million of Senior Unsecured Notes

California Resources Corporation Announces Private Offering of $550 Million of Senior Unsecured Notes

California Resources Corporation announced a $550 million private offering of senior unsecured notes due 2035. The company plans to use the proceeds along with other funds to redeem $550 million of its 8.250% senior notes due 2029 at a premium. The notes will be guaranteed by CRC's subsidiaries and offered only to qualified institutional buyers and…

Swvl Announces Q1 2026 Results; Revenue Up 68%; GCC Revenue Up 111%; Dollar-Pegged Revenue Up 111% and Net Dollar Retention of 114%

Swvl Announces Q1 2026 Results; Revenue Up 68%; GCC Revenue Up 111%; Dollar-Pegged Revenue Up 111% and Net Dollar Retention of 114%

Swvl Holdings announced Q1 2026 financial results showing robust 68% year-over-year revenue growth to $8.2 million, driven primarily by a 111% revenue increase in the GCC region. The company narrowed its operating loss by 71%, approaching breakeven, supported by operating leverage and disciplined cost management. Recurring revenue comprised 88% of …

Kite Realty Group Completes $136 Million in Strategic Acquisitions and $255 Million in Strategic Dispositions

Kite Realty Group Completes $136 Million in Strategic Acquisitions and $255 Million in Strategic Dispositions

Kite Realty Group completed strategic capital allocation moves including acquiring two high-growth grocery-anchored neighborhood centers for $136 million through 1031 exchanges, disposing six lower-growth non-core assets for $255 million, and repurchasing an additional 1.7 million shares. These actions aim to improve growth rate, quality, and durab…

VivoPower’s B Corporation Recertification Strengthens Its Sovereign Infrastructure Mandate; Tembo Qualified to Use B Corp Logo

VivoPower’s B Corporation Recertification Strengthens Its Sovereign Infrastructure Mandate; Tembo Qualified to Use B Corp Logo

VivoPower PLC has been recertified as a Certified B Corporation by B Lab, extending its continuous B Corp status to 2028, demonstrating verified governance, environmental, and stakeholder accountability standards. This certification strengthens VivoPower's credibility as a trusted partner for sovereign nations developing AI data center infrastructu…

Syntec Optics (Nasdaq: OPTX) Lands Space Optics Order, Boosting Total to $4.3M for Weekly Satellite Launches

Syntec Optics (Nasdaq: OPTX) Lands Space Optics Order, Boosting Total to $4.3M for Weekly Satellite Launches

Syntec Optics Holdings, Inc. announced new purchase orders totaling nearly $2.4 million for its space optics product line, expanding previous orders to nearly $4.3 million. These optics are critical for weekly Low Earth Orbit satellite launches, enabling high-speed, secure data transfer through nanoscale precision optics. The company's products pla…

Nocera Announces Strategic Investment in CampaignPulse.ai, Expanding Artificial Intelligence Portfolio and Advancing Nocera Holdings Growth Strategy

Nocera Announces Strategic Investment in CampaignPulse.ai, Expanding Artificial Intelligence Portfolio and Advancing Nocera Holdings Growth Strategy

Nocera, Inc. (Nasdaq: NCRA) announced a minority equity investment in CampaignPulse.ai, an emerging AI company developing simulation-driven campaign intelligence and predictive analytics tools. This investment aligns with Nocera's transformation into a diversified technology holding company focused on AI, digital infrastructure, robotics, biotech, …

Diana Shipping Inc. Reminds Genco Shipping & Trading Shareholders to Cast Their Vote for Independent, Fresh Perspectives in the Boardroom Ahead of Annual Meeting on June 18

Diana Shipping Inc. Reminds Genco Shipping & Trading Shareholders to Cast Their Vote for Independent, Fresh Perspectives in the Boardroom Ahead of Annual Meeting on June 18

Diana Shipping Inc., the largest shareholder of Genco Shipping & Trading Limited, calls on Genco shareholders to vote for Diana's nominees and against Genco’s poison pill and equity incentive plan which it claims protect current management at shareholders' expense. The proxy campaign highlights governance concerns including Genco's adoption of a po…

EquipmentShare Announces Launch of Private Offering of Notes

EquipmentShare Announces Launch of Private Offering of Notes

EquipmentShare.com Inc (Nasdaq: EQPT), a leading US construction equipment rental and connected jobsite technology company, announced a private offering of $1.05 billion in senior secured second lien notes due 2034. The proceeds will be used primarily to repay borrowings under its asset-based revolving credit facility and for general corporate purp…

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Outlook Therapeutics announced that the FDA has accepted the resubmitted Biologics License Application for their ophthalmic formulation of bevacizumab, ONS-5010/LYTENAVA™, intended to treat wet age-related macular degeneration (AMD). This marks a significant regulatory milestone with a PDUFA action date set for July 29, 2026. The drug is already au…

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Calidi Biotherapeutics announced positive pre-IND feedback from the US FDA regarding its lead candidate CLD-401, an oncolytic virus designed to deliver IL-15 superagonist genetically to treat solid tumors. The FDA's agreement on preclinical and clinical strategies paves the way for Calidi to submit its IND by year-end 2026 and initiate Phase 1 clin…

Sanuwave Health Updates Second Quarter 2026 Guidance

Sanuwave Health Updates Second Quarter 2026 Guidance

Sanuwave Health, Inc. revised its second-quarter 2026 revenue guidance downward to $8.5-$9.5 million due to market disruptions affecting sales of its Ultramist directed energy system. Despite robust unit sales of applicators, challenges such as widespread CMS reimbursement clawbacks and the emergence of a secondary market for used Ultramist systems…

EquipmentShare Assigned First-Time ‘BB-’ Issuer Default Rating by Fitch; Senior Secured Second Lien Notes Rated ‘BB’; Outlook Stable

EquipmentShare Assigned First-Time ‘BB-’ Issuer Default Rating by Fitch; Senior Secured Second Lien Notes Rated ‘BB’; Outlook Stable

EquipmentShare.com Inc, a leading US construction equipment rental and technology provider, received its first Fitch Long-Term Issuer Default Rating of 'BB-' with a Stable outlook. Fitch also assigned ratings of 'BB+' and 'BB' to EquipmentShare's asset-based lending revolving credit facility and senior secured second lien notes, respectively. The r…

BigCommerce Earns 2026 Top Rated Award From TrustRadius

BigCommerce Earns 2026 Top Rated Award From TrustRadius

Commerce.com, Inc., parent company of BigCommerce, announced that BigCommerce has received the 2026 Top Rated Award from TrustRadius, reflecting high customer satisfaction with its ecommerce platform. The award is based solely on verified customer reviews praising its features such as multi-brand storefront management, robust catalog handling, and …

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

BioAge Labs has dosed the first participant in the Phase 2 QUELL-CV trial evaluating BGE-102, a novel oral NLRP3 inhibitor aimed at reducing cardiovascular risk driven by inflammation. The randomized, placebo-controlled study will assess dose-ranging efficacy and safety in adults with elevated systemic inflammation and cardiovascular risk factors, …

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Cingulate Inc. announced the issuance of its first wholly owned U.S. patent for its lead ADHD asset, CTx-1301, covering its proprietary Precision Timed Release™ technology. The patent strengthens Cingulate's intellectual property portfolio and supports its progress toward potential commercialization of the once-daily ADHD treatment. The company foc…

authID and Trinsic Partner to Deliver Secure and Easily Deployable Biometric-Powered Digital Identity

authID and Trinsic Partner to Deliver Secure and Easily Deployable Biometric-Powered Digital Identity

authID has partnered with Trinsic to integrate Digital ID support into its Proof™ biometric identity platform. This collaboration enables organizations to verify users globally using trusted digital IDs combined with biometric authentication, enhancing security and privacy while simplifying compliance. The partnership significantly expands authID's…

Vera Bradley Debuts at Nordstrom Stores Nationwide and Nordstrom.com

Vera Bradley Debuts at Nordstrom Stores Nationwide and Nordstrom.com

Vera Bradley, Inc. (NASDAQ: VRA) has announced its debut at Nordstrom stores nationwide and on Nordstrom.com, marking its first-ever partnership with the major fashion retailer. The curated assortment includes a mix of new and relaunched highly popular products, aiming to expand brand reach, especially among Gen Z and millennial consumers. The init…